Table 2 Correlation between MMP-13 expression and clinicopathological parameters of chondrosarcoma patients.
Parameter | No. of patients | MMP-13 immunostaining | P-value | |
|---|---|---|---|---|
| Â | Â | MMP-13 (-ve) (n = 3) % | MMP-13 (+ve) (n = 8) % | Â |
Age | Â | Â | Â | Â |
   >60 | 6 | 2 (33.3%) | 4(66.7%) |  |
   ≤ 60 | 5 | 1 (20%) | 4 (80%) | NS |
Sex | Â | Â | Â | Â |
   Male | 7 | 2 (28.6%) | 5(71.4%) |  |
   Female | 4 | 1 (25%) | 3(75%) | NS |
Site | Â | Â | Â | Â |
   Mandible | 8 | 2 (25%) | 6(75%) |  |
   Maxilla | 3 | 1 (33.3%) | 2(66.7%) | NS |
Mitosis | Â | Â | Â | Â |
   0 | 3 | 3 (100%) | 0(0%) |  |
   1 | 4 | 0(0%) | 4(100%) |  |
   2 | 2 | 0(0%) | 2(100%) | *S |
   3 | 2 | 0 (0%) | 2 (100%) |  |
Necrosis | Â | Â | Â | Â |
   o | 5 | 3 (60%) | 2 (40%) |  |
   1 | 4 | 0 (0%) | 4 (100%) | *S |
   2 | 2 | 0 (0%) | 2 (100%) |  |
Grades | Â | Â | Â | Â |
   G-I | 4 | 3 (75%) | 1 (25%) |  |
   G-II | 5 | 0 (0%) | 5 (100%) | *S |
   G-III | 2 | 0 (0%) | 2 (100%) |  |
Recurrence | Â | Â | Â | Â |
   + | 3 | 0(0%) | 3 (100%) |  |
   - | 8 | 3 (37.5%) | 5 (62.5%) | NS |